Randolph-Macon Woman's College, B.S., 06/01, Biology University of Kentucky College of Medicine, M.D., 06/07 University of Virginia, Intern, 06/08, Internal Medicine University of Virginia, Resident, 06/10, Neurology University of Virginia Chief Resident, 06/11, Neurology Partners Neuro-Oncology Fellowship (Massachusetts General Hospital/Dana Farber Cancer Institute/Brigham and Women's Hospital), Clinical Fellow, 06/12, Neuro-Oncology Edwin L. Steele Lab of Tumor BiologyMassachusetts General Hospital, Research Fellow, 06/14, Neuro-Oncology Harvard School of Public Health, MPH, 06/14, Public Health

Honors & Awards

  • 2007
    General Clinical Research Center Medical/Dental Mentorship Award, University of Kentucky College of Medicine
  • 2010
    Chief resident in Neurology, University of Virginia College of Medicine
  • 2012
    K12 training grant recipient, "Training Program in Nervous System Tumors", Massachusetts General Hospital

Selected Publications

  1. Schulte JD, Buerki RA, Lapointe S, Molinaro AM, Zhang Y, Villanueva-Meyer JE, Perry A, Phillips JJ, Tihan T, Bollen AW, Pekmezci M, Butowski N, Oberheim Bush NA, Taylor JW, Chang SM, Theodosopoulos P, Aghi MK, Hervey-Jumper SL, Berger MS, Solomon DA, Clarke JL Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults.  View on PubMed
  2. Lukas RV, Taylor JW, Kurz SC, Mohile NA Clinical neuro-oncology for the neurologist.  View on PubMed
  3. Lucas CG, Gupta R, Doo P, Lee JC, Cadwell CR, Ramani B, Hofmann JW, Sloan EA, Kleinschmidt-DeMasters BK, Lee HS, Wood MD, Grafe M, Born D, Vogel H, Salamat S, Puccetti D, Scharnhorst D, Samuel D, Cooney T, Cham E, Jin LW, Khatib Z, Maher O, Chamyan G, Brathwaite C, Bannykh S, Mueller S, Kline CN, Banerjee A, Reddy A, Taylor JW, Clarke JL, Oberheim Bush NA, Butowski N, Gupta N, Auguste KI, Sun PP, Roland JL, Raffel C, Aghi MK, Theodosopoulos P, Chang E, Hervey-Jumper S, Phillips JJ, Pekmezci M, Bollen AW, Tihan T, Chang S, Berger MS, Perry A, Solomon DA Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumor.  View on PubMed
  4. Schulte JD, Aghi MK, Taylor JW Anti-angiogenic therapies in the management of glioblastoma.  View on PubMed
  5. Molinaro AM, Taylor JW, Wiencke JK, Wrensch MR Genetic and molecular epidemiology of adult diffuse glioma.  View on PubMed
  6. Chapman CH, Hara JH, Molinaro AM, Clarke JL, Oberheim Bush NA, Taylor JW, Butowski NA, Chang SM, Fogh SE, Sneed PK, Nakamura JL, Raleigh DR, Braunstein SE Reirradiation of recurrent high-grade glioma and development of prognostic scores for progression and survival.  View on PubMed
  7. Taylor JW, Armstrong T, Kim AH, Venere M, Acquaye A, Schrag D, Wen PY The lomustine crisis: awareness and impact of the 1500% price hike.  View on PubMed
  8. Taylor JW, Parikh M, Phillips JJ, James CD, Molinaro AM, Butowski NA, Clarke JL, Oberheim-Bush NA, Chang SM, Berger MS, Prados M Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastoma.  View on PubMed
  9. Wahl M, Chang SM, Phillips JJ, Molinaro AM, Costello JF, Mazor T, Alexandrescu S, Lupo JM, Nelson SJ, Berger M, Prados M, Taylor JW, Butowski N, Clarke JL, Haas-Kogan D Probing the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in gliomas: A phase 2 study of everolimus for recurrent adult low-grade gliomas.  View on PubMed
  10. Pekmezci M, Rice T, Molinaro AM, Walsh KM, Decker PA, Hansen H, Sicotte H, Kollmeyer TM, McCoy LS, Sarkar G, Perry A, Giannini C, Tihan T, Berger MS, Wiemels JL, Bracci PM, Eckel-Passow JE, Lachance DH, Clarke J, Taylor JW, Luks T, Wiencke JK, Jenkins RB, Wrensch MR Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT.  View on PubMed
  11. Clarke JL, Molinaro AM, Cabrera JR, DeSilva AA, Rabbitt JE, Prey J, Drummond DC, Kim J, Noble C, Fitzgerald JB, Chang SM, Butowski NA, Taylor JW, Park JW, Prados MD A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade glioma.  View on PubMed
  12. Taylor JW, Molinaro AM, Butowski N, Prados M Clinical trial endpoints for patients with gliomas.  View on PubMed
  13. Cabrera JR, Taylor JW, Molinaro AM Phase I cancer clinical trials.  View on PubMed
  14. Chan AK, Birk HS, Winkler EA, Viner JA, Taylor JW, McDermott MW Stability of Programmable Shunt Valve Settings with Simultaneous Use of the Optune Transducer Array: A Case Report.  View on PubMed
  15. Han SJ, Englot DJ, Birk H, Molinaro AM, Chang SM, Clarke JL, Prados MD, Taylor JW, Berger MS, Butowski NA Impact of Timing of Concurrent Chemoradiation for Newly Diagnosed Glioblastoma: A Critical Review of Current Evidence.  View on PubMed
  16. Han SJ, Rutledge WC, Molinaro AM, Chang SM, Clarke JL, Prados MD, Taylor JW, Berger MS, Butowski NA The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma.  View on PubMed
  17. Taylor JW, Schiff D Treatment considerations for MGMT-unmethylated glioblastoma.  View on PubMed
  18. Taylor JW, Dietrich J, Gerstner ER, Norden AD, Rinne ML, Cahill DP, Stemmer-Rachamimov A, Wen PY, Betensky RA, Giorgio DH, Snodgrass K, Randall AE, Batchelor TT, Chi AS Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma.  View on PubMed

Go to UCSF Profiles, powered by CTSI